Sentence examples for presentation size from inspiring English sources

Of the unique SDHB-related PHEO/PGL characteristics described above, extra-adrenal location, age at initial presentation, size of the primary tumor, and elevated methoxytyramine levels were introduced and confirmed as risk factors for the metastatic behavior of PHEOs/PGLs [ 11, 17- 19].

Whether they are pitching to venture capitalists, angel investors or friends and family, entrepreneurs who have been through the process stress the importance of making a crisp presentation, sizing up competitors and knowing what kind of information the potential investors require.

Pheochromocytomas vary in presentation, tumor size, and in catecholamine production.

Figure 3 TEM bright field micrographs of nanoparticles in different annealing conditions;a 450 °C,b 500 °C andc 600 °C Figure 4 TEM bright field micrographs (a c) of nanoparticles annealed at 700 °C Figure 5 Graphical presentation of size of nanoparticles with annealing temperature.

In order to further prove that the observed negative component is consistent with MMN, more detailed investigations will be required to examine MMN characteristics, such as presentation rate, size of deviance, and deviance probability dependence.

On imaging, RCC is indistinguishable from Wilms tumour but it is usually smaller at presentation (average size 4 cm).

Atypical carcinoid is larger than typical carcinoid at presentation (mean size 3.9 cm) and is more commonly associated with adenopathy (40%).

The records of these patients were reviewed, and the age, sex, presentation, tumour size, extent of tumour resection, clinical outcome and surgical complications of the patients were recorded.

The clinicopathological characteristics (age at presentation, tumour size, tumour grade, lymph node status, and ER/PR/Her2 status) were obtained from the diagnostic histopathology reports.

The value of the forecast depends on the accuracy - taking into consideration the type of vaccine, the presentation (vial size), the quantity and the timing of delivery of the vaccine.

Data collected included patient demographics and year of presentation, tumour size, grade, stage, histological type, extent of tumour invasion and lymph node involvement and the presence or absence of local or distant metastasis.